Molecular biomarkers offer a wealth of information that facilitates accurate cancer diagnosis and guides treatment strategies. Recent technological advances have unlocked the identification of diverse biomarker types, including extracellular vesicles (EVs), proteins, carbohydrates, DNA, and RNA. In this seminar, Anton Iliuk, Brian Haab, Yong Zeng, and Brian Cunningham will discuss innovative approaches to detect biomarkers for cancer diagnosis, prognosis, and treatment assessment.
Topics to be covered
- Developing non-invasive cancer diagnostics using EV protein biomarkers
- Probing glycan biomarkers for pancreatic cancer diagnosis and prognosis
- Engineering biosensors to profile EV biomarkers for cancer liquid biopsy
- Designing point-of-care cancer diagnostics for therapy monitoring
Wednesday, September 20th, 2023 | 1:30 PM - 4:00 PM Eastern Time
This seminar will be available to view live and on demand.
Speakers
Anton Iliuk, PhD
President and Chief Technology Officer
Tymora Analytical Operations
Brian Haab, PhD
Professor
Van Andel Institute
Yong Zeng, PhD
Associate Professor
University of Florida
Brian Cunningham, PhD
Intel Alumni Endowed Chair
University of Illinois at Urbana Champaign